Best Options Strategy for CRNX
Looking for the best options strategy for Crinetics Pharmaceuticals, Inc. (CRNX)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live CRNX option chain right now, and a simple map from your view on CRNX to the strategy that fits it. Model any of them in the calculator before you trade.
About CRNX
Crinetics Pharmaceuticals, Inc. (CRNX) is a major company in Biotechnology. Options traders on CRNX tend to watch , since these can drive large moves in the share price.
About Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals is a clinical-stage drug developer focused on treating rare endocrine disorders and hormone-related tumors. The company's most advanced candidate is Paltusotine, an oral medication designed to activate somatostatin receptor type 2, currently undergoing Phase 3 testing for acromegaly and carcinoid syndrome. Beyond its lead program, Crinetics is building a pipeline spanning multiple areas of endocrine disease. This includes Atumelnant, which blocks ACTH receptor signaling for conditions like Cushing's disease and congenital adrenal hyperplasia, along with programs targeting PTH receptor pathology, thyroid-stimulating hormone receptors, and newer initiatives in obesity treatment with oral GLP-1 and GIP candidates. The company also has a drug-conjugate candidate called CRN09682 aimed at somatostatin-receptor-positive solid tumors.
The company generates revenue primarily through licensing and partnership arrangements rather than product sales, given its clinical-stage status. It has licensed Paltusotine rights in Japan to Sanwa Kagaku Kenkyusho and granted development and commercialization rights for another somatostatin receptor agonist to Cellular…
Today's top-scoring strategy for CRNX
Our engine ranks defined-risk strategies on the live CRNX chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | CALL | $95 | $6.83 |
| Sell | 2× | CALL | $100 | $3.82 |
| Buy | 1× | CALL | $105 | $1.87 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Illustrative example at CRNX's latest available price, computed with the same engine as the tool. Live option fills and the real IV skew refresh during US market hours.
Implied volatility
CRNX typically trades with moderate implied volatility, broadly in line with other large-cap stocks. Implied volatility drives option prices, so it is worth checking the live chain before you trade.
Earnings & IV crush
CRNX's next earnings report is due around August 4, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Key figures
- Market cap
- $4.5B
- Beta (vs market)
- 0.24
- 52-week range
- $25.83–$57.99
- Short interest
- 14.3% of float · 13.4 days to cover
With 14.3% of CRNX's float sold short, squeeze and gap risk are elevated — one reason its options can stay expensive.
How to choose an options strategy for CRNX
Start with your outlook on CRNX, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while CRNX stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open CRNX in the free calculator →
Frequently asked questions
What is the best options strategy for CRNX?
It depends on your outlook. Bullish traders often use a long call or bull call spread on CRNX; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are CRNX options liquid enough to trade?
Crinetics Pharmaceuticals, Inc. (CRNX) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade CRNX options?
Buying a single CRNX call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade CRNX or any security. Do your own research.
What does Crinetics Pharmaceuticals, Inc. do?
Crinetics Pharmaceuticals, Inc. (CRNX) operates in the Biotechnology industry. The "About Crinetics Pharmaceuticals, Inc." section above gives a fuller picture of what the company does and how it earns money.
Does Crinetics Pharmaceuticals, Inc. pay a dividend?
Crinetics Pharmaceuticals, Inc. does not currently pay a dividend, so there is no ex-dividend assignment risk to plan around for options strategies.
When does Crinetics Pharmaceuticals, Inc. next report earnings?
Crinetics Pharmaceuticals, Inc.'s next earnings are expected around August 4, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Tickers related to CRNX
Comparing CRNX with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 6055 Lusk Boulevard, San Diego, CA, 92121, United States
- Industry
- Biotechnology
- Employees
- 594
- CEO
- Dr. R. Scott Struthers Ph.D.
- Phone
- 858 450 6464
- Website
- www.crinetics.com
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.